Envveno Medical CORP Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Northstrive Fund II LP and Braeden Lichti, holding a 5.05% stake, have filed a Schedule 13D urging enVVeno Medical Corp to halt clinical operations and explore strategic alternatives including liquidation or merger.
NASDAQ
Northstrive Fund II LP and Braeden Lichti, holding a 5.05% stake, demand enVVeno Medical Corp halt clinical operations and initiate a strategic review for capital return or merger.